BioReliance provides comprehensive toxicology services that can speedily move your product from discovery to market. We have been a scientific leader in toxicology for more than 50 years – from safety testing the first polio vaccines in the 1950’s to validating new transgenic mouse models for carcinogenicity testing.
BioReliance services include a broad spectrum of in vitro and in vivo toxicology testing services designed in accordance with international guidelines and are conducted in full compliance with GLP regulations. Our expertise uniquely qualifies us to custom design testing strategies even when they involve new or novel products. These services are provided to producers of traditional pharmaceuticals, biopharmaceuticals, medical devices, gene therapies, industrial chemicals and consumer products. Our 50,000 square foot, state-of-the-art facility and dedicated staff continue to lead and advance the field of toxicology with the implementation of the latest technologies that help clients register products internationally.
Our areas of expertise include:
BioReliance offers complete genetic toxicology services for the detection of toxic, mutagenic, clastogenic, and morphological transforming activity in a number of well-characterized test systems.
In Vitro ADME/Tox Testing
BioReliance now provides select in-vitro ADME and toxicology services that can rapidly move your product through preclinical testing and into development.
BioReliance has extensive experience in the development and application of toxicological methodologies using animal models.
BioReliance offers analytical services in support of toxicology studies including, method validation, formulation analysis, homogeneity and stability testing.
Contract Pathology Services
BioReliance offers comprehensive clinical and anatomic pathology services.